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Abstract
Purpose Anastomotic leakage (AL) is the most severe complication following colorectal resection and is associated with
increased mortality. The main group of enzymes responsible for collagen and protein degradation in the extracellular matrix is
matrix metalloproteinases. The literature is conflicting regarding anastomotic leakage and the degradation of extracellular
collagen by matrix metalloproteinase-9 (MMP-9). In this systematic review, the possible correlation between anastomotic
leakage after colorectal surgery and MMP-9 activity is investigated.
Methods Embase, MEDLINE, Cochrane, and Web of Science databases were searched up to 3 February 2020. All published
articles that reported on the relationship betweenMMP-9 and anastomotic leakage were selected. Both human and animal studies
were found eligible. The correlation between MMP-9 expression and anastomotic leakage after colorectal surgery.
Results Seven human studies and five animal studies were included for analysis. The human studies were subdivided into those
assessing MMP-9 in peritoneal drain fluid, intestinal biopsies, and blood samples. Five out of seven human studies reported
elevated levels of MMP-9 in patients with anastomotic leakage on different postoperative moments. The animal studies dem-
onstrated that MMP-9 activity was highest in the direct vicinity of an anastomosis. Moreover, MMP-9 activity was significantly
reduced in areas further proximally and distally from the anastomosis and was nearly or completely absent in uninjured tissue.
Conclusion Current literature shows some relation between MMP-9 activity and colorectal AL, but the evidence is inconsistent.
Innovative techniques should further investigate the value of MMP-9 as a clinical biomarker for early detection, prevention, or
treatment of AL.
Keywords Anastomotic leakage .Matrixmetalloproteinase . Colorectal surgery . Complications
Introduction
Anastomotic leakage (AL) is the most feared complication
following colorectal surgery and is associated with increased
short- and long-termmorbidity andmortality [1]. The reported
incidence of AL varies between 6 and 8% after colon resection
and between 7 and 20% after rectal resection [1–5]. Mortality
rates related to AL range from 15.6 to 16.4% and 5.7 to 9.9%,
for colonic and rectal resection, respectively [6–9]. Despite
extensive research and ongoing advances in colorectal sur-
gery, the incidence rates of AL have not declined over the last
decades [10].
The current golden standard, C-reactive protein (CRP), has
low-positive predictive accuracy for diagnosing AL [11].
Computer tomography is often added to increase the positive
predictive value, but is not accurate enough to provide assur-
ance of anastomotic integrity [12]. Early diagnosis of AL is of
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paramount importance because AL can result in higher mor-
bidity and mortality [13]. The pathophysiology of AL seems
multifactorial.
One potential element in the development of AL is degra-
dation of the extracellular matrix (ECM), which in healthy
tissue provides integrity and structure of intestinal tissue.
Degradation of extracellular collagen is necessary after tissue
injury, i.e., after surgery, in order to replace damaged tissue
with healthy tissue to support healing. However, when bal-
ance is disturbed and an excess of collagen is degraded in
proportion to newly produced collagen, this might lead to loss
of integrity of an anastomosis and consequently to AL.
Previously, experimental studies investigated the association
between matrix metalloproteinases (MMPs) and AL and con-
cluded that MMPs negatively affect anastomotic healing [14,
15]. Moreover, MMP inhibitors showed to enhance the break-
ing strength of colonic anastomoses during the early postop-
erative phase [16].
Specifically, matrix metalloproteinase-9, a zinc-dependent
enzyme, plays a role in degradation of especially the collagen
of which ECM is composed [17]. Until to date, it remains
unknown whether this association represents a causal relation-
ship or is a consequential effect of AL. In this systematic
review, the association between MMP-9 and AL after colo-
rectal surgery is assessed.
Materials and methods
This study was conducted in accordance with the guidelines in
the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement [18]. Review Manager
version 5.3 was used to perform statistical analyses. The pro-
tocol of this study was registered at the PROSPERO
International prospective register of systematic reviews (ID-
number: CRD140350).
Systematic literature search
A systematic search was conducted with the assistance of a
biomedical information specialist for studies assessing the as-
sociation of MMP-9 activity and anastomotic healing after
colorectal surgery. The Embase, MEDLINE, Cochrane, and
Web of Science databases were searched from inception to
January 24, 2019. An update of the search was performed
on February 3, 2020. Full search syntaxes and results per
database are shown in appendix 1.
Study selection
Two researchers (MG, PE) independently reviewed the iden-
tified articles by title and abstract. Subsequently, full-text re-
view was performed by two researchers (MG, CS) using
EndNote X9® for Windows (Clarivate Analytics,
Philadelphia, USA). Differences in article selection between
reviewers were resolved through consensus by a third re-
searcher (PE). Exclusion criteria included no full text avail-
able, article not published in a peer-reviewed journal, article
language other than English, case reports, review articles, me-
ta-analysis, letters, abstracts, or comments.
Data extraction
Data extraction was performed by one researcher (MG) and
validated by two other researchers (PE, CS). The following
study details were collected: author, year of publication, coun-
try of origin, study design, number of participating centers,
study length and length of follow-up, sample size, primary
endpoint, MMP-9 measurement method, MMP-9 measure-
ment moment, number of ALs, definition of AL, patient char-
acteristics (sex, age, BMI for human studies, weight for ani-
mal studies.), and operative characteristics (type of surgery,
surgical technique, hand-sewn or stapled anastomotic con-
struction, operative time).
Included studies were categorized into two subgroups: hu-
man and animal studies. Human studies were further divided
by type of measurement (e.g. peritoneal drain fluid, blood, or
intestinal tissue) and animal studies were further divided by
study outcome (e.g., studies assessing MMP-9 activity in re-
lation to AL or studies assessing MMP-9 activity at different
sites around a colorectal anastomosis). Discrepancies were
discussed among all three researchers until consensus was
reached. In case of uncertainties with regard to reported out-
comes, corresponding authors were contacted when possible.
Quality assessment
Study quality was assessed independently by two researchers
(MG, PE) using the Newcastle-Ottawa Scale (NOS) and
Methodological Index for Non-Randomized Studies
(MINORS) criteria [19, 20]. For animal studies, the
Systematic Review Centre for Laboratory Animal
Experimentat ion (SYRCLE) tool was used [21] .
Discrepancies in quality assessment outcomes were resolved
by discussion between researchers.
Results
Systematic literature search
Details of the study selection are provided in a PRISMA flow
diagram (Fig. 1). The systematic literature search yielded 637
articles. After title and abstract screening, 53 articles remained
for full-text review. A total of 12 articles were found eligible
for inclusion after full-text reading.
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Study characteristics and data extraction
Seven human studies were included as well as five animal
studies. Study characteristics for human and animal studies
are summarized in Tables 1 and 2, respectively. All seven in-
cluded human studies were prospective cohort studies of which
one with matched controls. Data on a total of 785 patients who
underwent colorectal resection and creation of an anastomosis
was available. The human studies were subdivided into those
assessing MMP-9 in peritoneal drain fluid, in intestinal biop-
sies, and in blood samples. Five studies used AL as primary
endpoint. One study included AL in a group of “major compli-
cations.” One study included AL in an infection group,
consisted of AL and intra-abdominal abscesses.
The animal studies were subdivided into those assessing
MMP-9 activity in relation to AL and those assessing MMP-
9 activity at different sites around the anastomosis. Four stud-
ies assessedMMP-9 activity at different sites around the anas-
tomosis and one study assessed MMP-9 activity in relation to
AL.
Definition and rates of anastomotic leakage
The included studies diagnosed AL mostly by clinical suspi-
cion confirmed by radiological or operative exploration.
Incidence of AL in the studies ranged from 1.1 to 34.5% with
a mean AL rate of 10.8%.
Quality assessment
Results from the quality assessment with the NOS, MINORS
instruments, and the SYRCLE tool are shown in Tables S1, S2
and S3, respectively. The MINORS instrument scored four
studies as of moderate quality and three of poor quality. The
degree of statistical heterogeneity among studies was estimat-
ed by calculating I2, as shown in Figs. 2 and 3, respectively.
The risk of bias assessed with the SYRCLE tool in the animal
studies was overall unclear or low. Three of the five animal
studies had high risk of bias on the item “sequence genera-
tion” for not describing if the allocation to groups was ade-
quately generated and applied. No study described the
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concealment of allocation, random housing, and blinding of
caretakers and therefore, the risk of bias for these items was
unclear for all studies. On all other items, the studies had low
risk of bias.
Human studies
Peritoneal drain fluid
Four studies assessed peritoneal drain fluid. Baker et al. includ-
ed 58 patients who underwent colorectal resection (e.g., right
hemicolectomy, left hemicolectomy, sigmoid colectomy, low
anterior resection, or Hartmann’s procedure) [22]. MMP-9 was
measured daily in peritoneal drain fluid using gelatinase activity
assays until the drain was removed. The number of ALs was
not specified from a group of 16 patients having major compli-
cations, but there was a significant positive correlation between
MMP-9 and postoperative complications and their severity on
postoperative day (POD) 6 and 7. No absolute values or confi-
dence intervals were reported [22].
Data of three other studies assessing peritoneal drain fluid
could be pooled for outcomes on POD 1. As shown in Fig. 2,
there was a significant difference in mean MMP-9 expression
in patients with and without anastomotic leakage. Two studies
assessing peritoneal drain fluid on POD 3 could also be com-
pared but differences in mean MMP-9 expression were not
significant (Fig. 3).
Kostić et al. measured MMP-9 activity in peritoneal drain
fluid from 150 patients using ELISA on day 1, 3, 5, and 7
postoperatively [23]. All patients underwent left-sided colo-
rectal resections. Of these patients, 15 (10%) developed AL.
No significant differences were observed in mean levels of
MMP-9 for patients with and without AL [23].
Pasternak et al. conducted a study in which MMP-9 levels
of 29 patients were measured in peritoneal drain fluid using a
particle-based multiplex flow-cytometry at a median of 4 h
(range 2–6 h) after low anterior resection [24]. Ten patients
(34.5%) developed AL. Significant higher levels of MMP-9
were found in patients who later developed AL with a median
difference of 1180 ng/ml (95% CI 141–3050, p = 0.03) [24].
The study of Sparreboom et al. analyzed 292 patients who
underwent partial mesorectal excision or total mesorectal ex-
cision [25]. MMP-9 levels in peritoneal drain fluid were mea-
sured on POD 1, 2, and 3 using immunoassays. A total of 38
patients (13%) developed AL. They found significant higher
levels of MMP-9 in patients with AL compared with patients
without AL on POD 3 (2.0 × 105 pg/mL IQR 0.5–5.0 vs.
0.6 × 105 pg/mL IQR 0.3–1.5, p = 0.011). On POD 1 and 2,
the MMP-9 levels in patients with AL were also higher; how-
ever, these differences were statistically not significant. In
addition, this study showed that the combination of serum
CRP and peritoneal MMP-9 on POD 3 was predictive for
AL (AUC =0.78) [25].
Intestinal tissue
Two studies measured MMP-9 in intestinal tissue samples.
Angenete et al. measured MMP-9 in 61 patients using
ELISA on biopsies taken from the resected rectal segment,
which was snap frozen in liquid nitrogen during surgery
[26]. These patients underwent low anterior resection, only
one of 61 patients (1.6%) developed AL and no correlation
with MMP-9 was found [26]. Stumpf et al. used an immuno-
reactive score to measure MMP-9 activity in biopsies taken
from the resected colorectal segment during surgery, which
were paraffin-embedded [27]. This score ranged from 1 with
low amounts ofMMP-9 positive cells to 20with high amounts
ofMMP-9 positive cells. In 119 patients, a colorectal resection
was performed in which 15 (12.6%) of them developed AL.
Type of surgical resection was not further specified.
Significant higher MMP-9 scores were found in the submu-
cosal layers of patients with AL compared with those without
Fig. 2 Forest plot of cohort studies comparing anastomotic leakage and non-anastomotic leakage on MMP-9 activity in peritoneal drain fluid on
postoperative day 1
Fig. 3 Forest plot of cohort studies comparing anastomotic leakage and non-anastomotic leakage on MMP-9 activity in peritoneal drain fluid on
postoperative day 3
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AL (median = 13, IQR (11–14) vs. median = 11, IQR (9–13)
(p < 0.05)) [27]. These scores were measured manually from
figures in the article, since exact data could not be retrieved
after consultation of the author.
Blood samples
In a cohort of 340 patients, Alonso et al. investigated expres-
sion of genes coding for MMP-9 in peripheral blood
leucocytes using microarray expression profiles from blood
samples obtained 4 days after surgery, or earlier in case AL
was diagnosed [28]. Validation of the expression profiles was
done with RT-PCR. The patients underwent colorectal sur-
gery without further characterization. In this cohort, 21 pa-
tients (6.2%) developed AL, 23 patients (6.8%) acquired an
infection, and 2 (0.6%) patients were diagnosed with an intra-
abdominal abscess. These patients were matched for gender,
age, tumor location, surgical approach, date of operation, and
tumor stage according to the TNM classification with healthy
controls who had an uncomplicated postoperative course.
Genes coding for MMP-9 were significantly upregulated in
the infection group compared with their controls (4.9-fold
change, p < 0.001). RT-PCR validation also found significant
higherMMP-9 mRNA levels in patients in the infection group
(p = 0.001) [28].
Animal studies
MMP-9 in relation to AL
The study of Shogan et al. measured MMP-9 activity in rats
using zymography and western blots [29]. Fifteen rats
underwent a colon segment resection of 1 cm at the peritoneal
reflection with devascularization. MMP-9 activity was higher
in extracted tissue of rats with AL compared with rats with
healed anastomotic tissue. Pharmacologic inhibition ofMMP-
9 resulted in suppressed MMP-9 and lower AL rates [29]. In
this study, the number of rats developingALwas not specified
and absolute values or confidence intervals were not reported.
MMP-9 at different sites around anastomosis
Four studies assessed MMP-9 at different sites around the
anastomosis. Ågren et al. analyzed MMP-9 activity in rats
using immunohistochemistry on POD 0, 3, or 7 [30].
Measurement was done with resection of a 3-cm segment
where the anastomosis was centrally located. No MMP-9 re-
activity was found at any site on POD 0. On POD 3 and 7,
more MMP-9 positive cells were found in the anastomotic
wound area compared with the adjacent uninjured areas prox-
imally and distally from the anastomosis. Moreover, the
MMP-9 levels directly around the sutures were higher
compared with the suture-free zone of the anastomotic wound
area [30].
De Hingh et al. used zymography on POD 0 (no interven-
tion), 1, or 3 to measure MMP-9 activity in 12 rats [31]. Six
rats were included in the control group; this group was
sacrificed without any intervention. From the other six rats,
the distal colon was transected, and an anastomosis was cre-
ated. On POD 1 or 3, a 2.5-cm segment with the anastomosis
was resected. In the uninjured colon of the control group,
MMP-9 activity could not be found. Furthermore, significant
higher MMP-9 activity was found on POD 1 and 3 in the area
of the anastomosis compared with uninjured colon proximally
and distally from the anastomosis (p < 0.001) [31].
Seifert et al. investigated MMP-9 activity measured with
zymography in 18 rats [32]. Three rats were included in the
control group and were sacrificed without undergoing any
operation. The other 15 rats underwent a 1-cm colon segment
resection and were sacrificed on POD 1, 2, 3, 7, or 90, after
which a 0.5-cm segment together with the anastomosis was
resected. No MMP-9 activity was found in the uninjured con-
trol group or on POD 90. At other time points, measured
MMP-9 activity was significantly higher directly around the
anastomosis compared with uninjured tissue [32].
Shaper et al. measured MMP-9 activity in 40 rabbits using
immunohistochemistry and zymography [33]. A distal 0.5-cm
segment of the colon was resected and an anastomosis was
created. The resected segment was used as control for analy-
sis. Half of the rabbits were sacrificed on POD 0 and the other
half on POD 7, after which a 1-cm segment with the anasto-
mosis centralized was resected. MMP-9 was not detected by
immunohistochemistry in the control group, but in some con-
trols,MMP-9 activity was found with zymography. There was
moreMMP-9 activity around the anastomosis on POD 0 and 7
compared with the control segments and adjacent uninjured
colon segments distal and proximal from the anastomosis.
In summary, in animal models, MMP-9 expression was
higher in the area of anastomosis compared with uninjured
tissue. Also, MMP-9 expression was highest near the anasto-
mosis and decreased further away from it.
Discussion
This systematic review shows that there is a connection be-
tween patients with AL or infectious complication and elevat-
ed levels of MMP-9 on different postoperative moments in
five out of seven human studies [22, 24, 25, 27, 28]. Two
other human studies did not find a significant difference in
MMP-9 levels [23, 26]. These studies by Kostić et al. and
Angenete et al. diagnosed AL only clinically, without radio-
logical confirmation, which is in contrast with other studies.
Although the value of radiological detection of AL is ques-
tionable, this could possibly explain the difference in outcome
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between the studies [34, 35]. In addition, in the study by
Angenete et al., only one of 91 patients developed AL and
the study by Baker et al. did not specify the amount or per-
centage of AL. Presumably this was caused by a heterogenous
study population, that also included abdominoperineal resec-
tions. With such a small event size and heterogenous popula-
tion, it is unlikely to detect a possible correlation.
A potential element in the development of AL is degrada-
tion of the extracellular matrix (ECM), which in healthy tissue
provides integrity and structure of intestinal tissue.
Degradation of extracellular collagen is necessary after tissue
injury, i.e., after surgery, in order to replace damaged tissue
with healthy tissue. Imbalances in collagen degradation are
possibly caused by members of the intestinal commensal mi-
croflora. Shogan et al. showed that numbers of several
Enterococcus species, including Enterococcus faecalis, were
increased in anastomotic tissue after anastomosis construction
[36]. Another study reported that Enterococcus faecalis has
the capacity to degrade collagen and support MMP-9 activa-
tion [29]. Therefore, the increase of MMP-9 levels could play
a role in early detection and in innovative treatment strategies
to minimize the consequences of infection and AL in the near
future.
Previous studies have assessed the influence of MMP inhi-
bition, includingMMP-9, on anastomotic healing. These stud-
ies showed that anastomotic breaking strength is increased
after MMP inhibition [16, 37, 38]. However, no increase in
collagen levels was found in the analyzed segments. It is sug-
gested that collagen levels were not increased because only a
small amount of tissue directly adjacent to the sutures and
anastomosis was involved. By analyzing the whole anasto-
motic segment, including adjacent non-involved tissue, in-
crease of collagen might be too subtle to detect [37].
The animal study that assessed the relation between MMP-
9 and AL also showed higher MMP-9 activity in intestinal
tissue in animals with AL [29]. Furthermore, our subgroup
of animal studies assessing MMP-9 at different sites around
the anastomosis was consistent in their findings. These studies
showed that MMP-9 activity was highest directly around an
anastomosis. Also, MMP-9 activity was significantly reduced
in areas adjacent proximally and distally from the anastomosis
and was nearly or completely absent in uninjured tissue. This
confirms that loss of anastomotic strength due to MMP-9 ac-
tivity and loss of collagen is a very localized process.
Previous systematic reviews have investigated the role of
several biomarkers in the prediction and diagnosis of colorec-
tal AL, including MMP-9. Cini et al. concluded in 2013 in a
review of two studies assessing MMP-9 that patients with AL
had higher levels of peritoneal MMP-9 in drain fluid than
patients without AL [39]. On the other hand, two reviews from
2017 by Su’a et al. and Wright et al. had inconsistent or no
conclusions on the role of MMP-9 in the diagnosis and detec-
tion of colorectal AL [40, 41].
There are some limitations to the present study that are
important to acknowledge. At first, there was substantial
methodological heterogeneity between included studies. In
particular there was a variance in measurement, both frequen-
cy and specific days ofMMP-9measurement were reasons for
incomparability of the peritoneal drain fluid studies.
Therefore, pooling data for a meta-analysis was impossible.
The definition for AL too varied between the studies, even in
studies published after the proposed grading system by the
International Study Group of Rectal Cancer [42].
Furthermore, the included studies were all observational or
experimental and were classified as of low or moderate qual-
ity. Moreover, this systematic review also included animal
studies to collect all possible evidence with regard to MMP-
9 and anastomotic leakage. Conclusions drawn from these
studies should be handled delicately since findings are not
always transferable to human physiology.
This is the first review to report on the association between
MMP-9 activity and anastomotic leakage. Understanding the
pathophysiology to be able to detect AL in an early stage is of
paramount importance in daily clinical practice. It is of great
clinical value to investigate whetherMMP-9 could function as
a biomarker for AL or as an innovative strategy for prevention
and treatment via specific MMP inhibitors. The study of
Sparreboom et al. already showed the predictive value of
MMP-9 in addition to CRPwith regard to AL. Future research
should focus on a standardized method and a high-quality
prospective study to assess the role of MMP-9 in the develop-
ment of AL after colorectal surgery. New sensors and mea-
surement methods are warranted to clarify the potential of
MMP-9 as a clinical biomarker.
In conclusion, current literature shows some relation be-
tween MMP-9 activity and colorectal AL, but current evi-
dence is inconsistent. Innovative techniques should further
investigate the value of MMP-9 as a clinical biomarker for
early detection, prevention, or treatment of AL.
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